Cargando…
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs
Due to its antiangiogenic and anti-immunomodulatory activity, thalidomide continues to be of clinical interest despite its teratogenic actions, and efforts to synthesize safer, clinically active thalidomide analogs are continually underway. In this study, a cohort of 27 chemically diverse thalidomid...
Autores principales: | Peach, Megan L., Beedie, Shaunna L., Chau, Cindy H., Collins, Matthew K., Markolovic, Suzana, Luo, Weiming, Tweedie, David, Steinebach, Christian, Greig, Nigel H., Gütschow, Michael, Vargesson, Neil, Nicklaus, Marc C., Figg, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730988/ https://www.ncbi.nlm.nih.gov/pubmed/33276504 http://dx.doi.org/10.3390/molecules25235683 |
Ejemplares similares
-
In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems
por: Beedie, Shaunna L., et al.
Publicado: (2016) -
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injury
por: Lecca, Daniela, et al.
Publicado: (2023) -
Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
por: Huang, Phoebe A., et al.
Publicado: (2019) -
Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model
por: Beedie, Shaunna L., et al.
Publicado: (2016) -
Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments
por: Jung, Yoo Jin, et al.
Publicado: (2019)